login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
All US stocks
All Canadian stocks
All European stocks
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Account
Disclaimer
Affiliate
Contact
Privacy
CYTOKINETICS INC (CYTK) Stock News
NASDAQ:CYTK -
US23282W6057
-
Common Stock
38.34
USD
+0.29 (+0.76%)
Last: 8/22/2025, 8:01:24 PM
38.34
USD
0 (0%)
After Hours:
8/22/2025, 8:01:24 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
CYTK Latest News, Press Relases and Analysis
All
Press Releases
3 days ago - By: Cytokinetics, Incorporated
Cytokinetics Names Jim Daly to Board of Directors
4 days ago - By: Cytokinetics, Incorporated
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
16 days ago - By: Zacks Investment Research
- Mentions:
STRO
Cytokinetics (CYTK) Reports Q2 Loss, Tops Revenue Estimates
16 days ago - By: The Motley Fool
CYTK Earnings Jump 3,065%
16 days ago - By: Cytokinetics, Incorporated
Cytokinetics Reports Second Quarter 2025 Financial Results and Provides Business Update
16 days ago - By: Benzinga
- Mentions:
GSAT
PGY
ADV
REAL
...
Earnings Scheduled For August 7, 2025
17 days ago - By: Zacks Investment Research
- Mentions:
TECH
Techne (TECH) Beats Q4 Earnings and Revenue Estimates
a month ago - By: Cytokinetics, Incorporated
Cytokinetics to Announce Second Quarter Results On August 7, 2025
a month ago - By: Cytokinetics, Incorporated
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
a month ago - By: Cytokinetics, Incorporated
Cytokinetics Announces Five Presentations Related to Aficamten at the European Society of Cardiology Congress 2025
2 months ago - By: Yahoo Finance
- Mentions:
JPM
Piper Sandler Maintains a Buy Rating on Cytokinetics (CYTK) With a $107 PT
2 months ago - By: Cytokinetics, Incorporated
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2 months ago - By: Yahoo Finance
- Mentions:
JPM
INSM
JAZZ
BBIO
...
Cytokinetics, Incorporated (CYTK) Price Target Lowered To $53 from $71 at JPMorgan
2 months ago - By: Yahoo Finance
- Mentions:
VZ
HELOC rates reverse course while home equity loans stay steady
2 months ago - By: Yahoo Finance
- Mentions:
RJF
RNA
NET
CNXC
...
Avidity Biosciences, Inc. (RNA) Initiated with a Strong Buy at Raymond James
2 months ago - By: Yahoo Finance
- Mentions:
AXSM
MS
VZ
INSM
...
Axsome’s AXS-14 Gets Regulatory Setback with RTF, says Morgan Stanley
2 months ago - By: Yahoo Finance
- Mentions:
BBIO
SNAP
TM
ADBE
...
BridgeBio Pharma, Inc. (BBIO) Price Target Raised to $56 from $53 at H.C. Wainwright
2 months ago - By: Yahoo Finance
- Mentions:
VZ
LEU
SJM
A complete guide to SEP IRAs: Why those who are self-employed should take a look
2 months ago - By: Yahoo Finance
- Mentions:
UAL
DAL
CLF
MSFT
...
Prediction: Buying Delta Air Lines Stock Today Will Set You Up for Life
2 months ago - By: Yahoo Finance
- Mentions:
NVDA
AMD
META
QCOM
...
UK Regulator Partners with Nvidia to Help Banks Test AI Tools
2 months ago - By: Yahoo Finance
- Mentions:
OKLO
NET
CNXC
NVDA
...
Why Oklo Stock Rocketed Almost 30% Higher Today
2 months ago - By: Cytokinetics, Incorporated
Cytokinetics Announces Call For Proposals For Annual Corporate Giving Program
3 months ago - By: Zacks Investment Research
- Mentions:
VRTX
Cytokinetics (CYTK) Down 1.9% Since Last Earnings Report: Can It Rebound?
3 months ago - By: Cytokinetics, Incorporated
Cytokinetics to Participate in the Jefferies Global Healthcare Conference
3 months ago - By: Cytokinetics, Incorporated
Cytokinetics Presents Additional Data Related to Aficamten at the European Society of Cardiology Heart Failure 2025 Congress
3 months ago - By: Cytokinetics, Incorporated
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
3 months ago - By: Cytokinetics, Incorporated
Cytokinetics to Host Symposium on Contemporary Landscapes in Muscle Biology
3 months ago - By: Cytokinetics, Incorporated
Cytokinetics Announces Positive Topline Results From MAPLE-HCM
4 months ago - By: Glancy Prongay & Murray LLP
Securities Fraud Investigation Into Cytokinetics, Incorporated (CYTK) Announced – Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm
4 months ago - By: Cytokinetics, Incorporated
Cytokinetics Announces Four Upcoming Presentations at the European Society Of Cardiology Heart Failure 2025 Congress
4 months ago - By: Law Offices of Howard G. Smith
Cytokinetics, Incorporated (CYTK) Investors Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
4 months ago - By: Law Offices of Frank R. Cruz
Securities Fraud Investigation Into Cytokinetics, Incorporated (CYTK) Announced – Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz
4 months ago - By: Yahoo Finance
- Mentions:
APLS
ZG
IDCC
CNM
...
Why Apellis Pharmaceuticals Wilted on Wednesday
4 months ago - By: Cytokinetics, Incorporated
Cytokinetics to Hold Annual Meeting of Stockholders
4 months ago - By: Zacks Investment Research
- Mentions:
SNY
Cytokinetics Q1 Earnings Beat, Aficamten Target Action Date Extended
4 months ago - By: Zacks Investment Research
- Mentions:
MIRM
Cytokinetics (CYTK) Reports Q1 Loss, Lags Revenue Estimates
Please enable JavaScript to continue using this application.